The identification of mitochondrial, ER, calcium-signaling, synaptic, apoptotic, proteostatic, and cytoskeletal proteins accumulating in Alzheimer’s disease and cardiovascular disease aggregates suggests their potential as biomarkers for diagnosis and progression tracking of such diseases. This evidence concerns the gene DNM2 and Alzheimer disease.